Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
green tea + ganoderma lucidum
- Development stage
- Preclinical
- Lead developer
- Pharmanex
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Green tea + Ganoderma lucidum is a combination dietary supplement or beverage that blends extracts or powders of Camellia sinensis (green tea) and Ganoderma lucidum (also known as reishi mushroom). Both ingredients have long histories in traditional medicine for promoting general health and longevity. Scientific studies suggest this combination may have synergistic effects on immune modulation and cancer prevention. In vitro and animal studies indicate the blend can inhibit tumor growth, suppress cell proliferation, reduce invasiveness of cancer cells (notably breast cancer), enhance antioxidant activity, support immune function, reduce stress, and promote balanced energy. The mechanism appears to involve downregulation of oncogenes such as c-myc and suppression of urokinase plasminogen activator secretion in cancer cells[1][3][6]. This product is marketed primarily as a wellness beverage or supplement rather than a pharmaceutical drug.
- Brand names
- GanogreenReishi & Green TeaOrgano Organic Green Tea
- Other names
- green tea and reishi mushroomgreen tea with ganoderma lucidumreishi green tea
02
Targets
PLAU (uPA)MYC (MYC proto-oncogene protein)
Beyond the preview
Go deeper on green tea + ganoderma lucidum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on green tea + ganoderma lucidum.